C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2002
11/20/2002	EP1257282A1 Pancreatic stem cells and their use in transplantation
11/20/2002	EP1257168A1 Method of cryopreserving selected sperm cells
11/20/2002	EP1011697A4 Targeted system for removing tumor cells from cell populations
11/20/2002	EP1001758B1 Method of screening of potential drugs against obesity, capable of modulating the regulation of ucp-2
11/20/2002	EP0832268B1 A method of expressing and secreting soluble extracellular domains of humain gonadotropin hormone receptors
11/20/2002	EP0813442B1 Method for enriching rare cell population
11/20/2002	EP0779931B1 Methods for calcium phosphate transfection
11/20/2002	EP0758394B1 Bifunctional protein, preparation and use
11/20/2002	CN1380884A Novel recombinant antibodies, amino acid sequences of CDR thereof and genes encoding the same
11/20/2002	CN1380418A Cotton fibrocyte expression vector plasmid of spider silk gene
11/20/2002	CN1380417A Poplar chloroplast site-specific transformation method and DNA sequence for said method
11/20/2002	CN1380341A Single-stranded cyctic trispecific antibody
11/20/2002	CN1379989A Glycooxidase and its application in baking process
11/19/2002	US6483012 Methods for producing parthenocarpic or female sterile transgenic plants and methods for enhancing fruit setting and development
11/19/2002	US6483010 DNA molecules encoding enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing these molecules
11/19/2002	US6483008 Methods for producing plants with elevated oleic acid content
11/19/2002	US6482937 Porcine Oct-4 promoter
11/19/2002	US6482935 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002	US6482929 Antibodies to ARF-p19
11/19/2002	US6482927 Chimeric proteins comprising the extracellular domain of murine Ob receptor
11/19/2002	US6482926 Antibody compositions for preparing enriched cell preparations
11/19/2002	US6482925 Mutants of the LAG-3 proteins and nucleotides encoding LAG-3 mutants
11/19/2002	US6482647 Evolving susceptibility of cellular receptors to viral infection by recursive recombination
11/19/2002	US6482645 Methods and compositions for producing artificial fascia
11/19/2002	US6482633 Accessory functions for use in recombinant AAV virion production
11/19/2002	US6482628 Multiply-substituted protease variants
11/19/2002	US6482624 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/19/2002	US6482623 Lipid kinase
11/19/2002	US6482618 Self-enhancing, pharmacologically controllable expression systems
11/19/2002	US6482616 RCA-free adenoviral vector system and propagation method
11/19/2002	US6482610 Method for producing agents for treating tumor diseases and for immunosuppression
11/19/2002	US6482609 Isolated human EDG-4 receptor and polynucletide encoding said receptor
11/19/2002	US6482599 Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such
11/19/2002	US6482598 Antibody recognizing a small subset of human hematopoietic cells
11/19/2002	US6482586 Hybrid compositions for intracellular targeting
11/19/2002	US6482585 Storage and maintenance of blood products including red blood cells and platelets
11/19/2002	US6482410 Mediation of neuronal attachment and enhancement of the outgrowth of neutites
11/19/2002	US6482406 Cell-based gene therapy for the pulmonary system
11/19/2002	US6482231 Biological material for the repair of connective tissue defects comprising mesenchymal stem cells and hyaluronic acid derivative
11/19/2002	CA2312667C Novel cytokine
11/19/2002	CA2261579C Isolated peptides derived from mage-2
11/19/2002	CA2216870C Compositions and methods for regulating hair growth
11/19/2002	CA2091700C A non-mitogenic competitive hgf antagonist
11/19/2002	CA2040793C Plasmids expressing patatin and adp-glucose-pyrophosphorylase sequences
11/19/2002	CA1341400C Process for preparing proteins
11/19/2002	CA1341399C Intercellular adhesion molecules and their binding ligands
11/18/2002	CA2385735A1 A method of selecting an antibody, a hybridoma, a monoclonal antibody and use thereof
11/14/2002	WO2002090981A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof
11/14/2002	WO2002090926A2 Dose response-based methods for identifying receptors having alterations in signaling
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090558A1 Novel expression vectors and uses thereof
11/14/2002	WO2002090553A2 Recombinant fusion proteins and the trimers thereof
11/14/2002	WO2002090549A2 Compositions and methods for the modulation of viral maturation
11/14/2002	WO2002090533A2 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
11/14/2002	WO2002090532A1 Novel mutation
11/14/2002	WO2002090531A2 Peptidylarginine deiminase 6
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090529A1 Dna molecules encoding macaca mulatta androgen receptor
11/14/2002	WO2002090528A1 Soft tissue devices and methods of use
11/14/2002	WO2002090524A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	WO2002090523A2 Methods for the production of tyrosine, cinnamic acid and para-hydroxycinnamic acid
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090514A2 Epidermal growth factor receptorantisense oligonucleotides
11/14/2002	WO2002090511A2 Method for the isolation of stem cells by immuno-labeling with hla/mhc gene product marker
11/14/2002	WO2002090509A2 Materials and methods for producing tomato yellow leaf curl virus resistance in plants
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090495A2 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins
11/14/2002	WO2002090493A2 Δ4-desaturase genes and uses thereof
11/14/2002	WO2002090382A2 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
11/14/2002	WO2002089832A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	WO2002089747A2 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	WO2002089746A2 Hematopoietic stem cell chimerism to treat autoimmune disease
11/14/2002	WO2002089737A2 Separation of platelets from whole blood for use as a healant
11/14/2002	WO2002089726A2 Method of making a homogeneous preparation of hematopoietic stem cells
11/14/2002	WO2002089586A1 Lung epithelial cell line for propagating viruses
11/14/2002	WO2002089567A2 Sca2 knockout animal and methods of use
11/14/2002	WO2002089566A1 Interstitial prostatism model animal
11/14/2002	WO2002078439A3 Prevascularized constructs for implantation to provide blood perfusion
11/14/2002	WO2002077159A3 End group activated polymers with oligonucleotide ligands
11/14/2002	WO2002072605A3 Expression technology for proteins containing a hybrid isotype antibody moiety
11/14/2002	WO2002067764A3 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
11/14/2002	WO2002064756A9 Stem cell identification
11/14/2002	WO2002048317A3 Method and device for producing biological tissue in a growth chamber
11/14/2002	WO2002044341A3 Method and apparatus for multi-layer growth of anchorage-dependent cells
11/14/2002	WO2002034890A3 Pluripotential stem cells
11/14/2002	WO2002028906A3 Regulation of human sphingosine kinase-like protein
11/14/2002	WO2001031036A9 Modified viral surface proteins which bind to cells of tumor vasculature
11/14/2002	WO2001019842A9 Subunit optimized fusion proteins
11/14/2002	US20020170091 Acyl CoA:cholesterol acyltransferase related nucleic acid sequences
11/14/2002	US20020170084 Process for obtaining plant dna fragment and use thereof
11/14/2002	US20020169305 Nucleotide sequences coding polypeptide for use in the treatment and prevention of malaria
11/14/2002	US20020169304 Nucleotide sequences coding polypeptide for use in the classification, diagnosis, prevention and treatment of downe's syndrome and alzheimers's diseases
11/14/2002	US20020169301 Nucleotide sequences coding polypeptide for use in the diagnosis and treatment of cell proliferative disorders
11/14/2002	US20020169284 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system, virus, and visoin disorders
11/14/2002	US20020169132 Polypeptides
11/14/2002	US20020169125 Fusion protein such as of polyglutamic acid and interferon-alpha; improves bioactivity and water-solubility properties of a drug to which it is conjugated
11/14/2002	US20020169122 Chondrogenic potential of human bone marrow-derived CD105+ cells by BMP
11/14/2002	US20020169117 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/14/2002	US20020169066 Dense porous structures for use as bone substitutes
11/14/2002	US20020168770 Process for the induction of normal roots on nodes and internodes of stem segements without using hormones and / or other chemical treatments in metha species

1 ... 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 ... 1827